1. In a blow to its biggest revenue driver, Indivior loses patent battle with generics maker Alvogen  Endpoints News
  2. Indivior loses patent battle for Suboxone Film  BioPharma Dive
  3. Indivior shares hit by suboxone patent ruling  MarketWatch
  4. Full coverage